Showing results (51-60 of 255) with videos related to
Sort By:
Pageof 26
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 24, 2004
[Methodological bases for problem solution of monitoring and estimation of mental health services activity: national and international aspects]V S Iastrebov, V G Mitikhin, A A Churkin, et al.Meditsinskaia Tekhnika|March 1, 2003
[Lighting and technical elements of medical illuminators and the principles of minimal heating of the surgical field]Iu N Filippovskiĭ, V A Viktorov, D V Agafonov, et al.Khirurgiia|December 10, 2020
[Fast-track recovery for perforated duodenal ulcer]A I Khripun, A N Alimov, S A Asratyan, et al.Problemy Tuberkuleza|January 1, 1997
[Significance of activities of a medical sanitary detachment from complex expedition if the USSR Academy of Sciences (1925-1930) in the development of surgical treatment for osteoarticular tuberculosis in Iakutiia]V A Churkin, K G Basharin, M V Sleptsov, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1997
HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1M Schechter, L H Moulton, L H HarrisonArchives of Biochemistry and Biophysics|August 12, 1999
Highly efficient inhibition of human chymase by alpha(2)-macroglobulinM Walter, R M Sutton, N M SchechterPhysical Review Letters|February 7, 2003
Magnetic response of disordered metallic rings: large contribution of far levelsM Schechter, Y Oreg, Y Imry, et al.Research in Microbiology|September 5, 2012
Carbon source and cell density-dependent regulation of type III secretion system gene expression in Pseudomonas syringae pathovar tomato DC3000Jennifer L Stauber, Ekaterina Loginicheva, Lisa M SchechterBiological Chemistry|January 15, 2004
Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitorTrevor Selwood, Kyle C Elrod, Norman M SchechterAIDS (London, England)|April 20, 1999
Protease inhibitors as initial therapy for individuals with an intermediate risk of HIV disease progression: is more necessarily better?M Schechter, C J Struchiner, L H HarrisonPageof 26